Clinical Trials Logo
  1. Home
  2. Gout Flare
  3. NCT05936268

Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare — Gensci 048-203  

Gout Flare Clinical Trial

Official title:
A Randomized, Open Lable, Multi-center, Active Competitor Phase 2 Study for Evaluating Efficacy and Safety of Genakumab for Injection as First Line Therapy in Patients With Gout Flare

Clinical Trial Summary

To evaluate the safety and efficacy of Genakumab for Injection in patients with gout flare as a first line therapy

Clinical Trial Description

Phase 2， randomized, open lable, multi-center, active controlled study. Patients are randomized to Genakumab 200mg single injection group or Etoricorxib 120mg qd po.(until remission or intorlerance, no longer than 8 days) group. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05936268
Study type Interventional
Source GeneScience Pharmaceuticals Co., Ltd.
Contact Ting Liu
Phone 13644409526
Email Liuting01@gensci-china.com
Status Recruiting
Phase Phase 2
Start date June 30, 2023
Completion date February 21, 2024
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05522504 - Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout
Terminated NCT03933007 - Relation Between Blood Concentration of Colchicine and Response to Colchicine Treatment in Gout Flare Phase 4
Not yet recruiting NCT04069325 - Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy N/A
Recruiting NCT05586958 - Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients Phase 3
Active, not recruiting NCT06197828 - Novel Biomarkers for Early Renal Injury in Children With Sepsis
Recruiting NCT05586971 - Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients Phase 3
Not yet recruiting NCT04849312 - Prediction of 30-Day Readmission Using Machine Learning
Active, not recruiting NCT05045742 - Prediction of Patient Deterioration Using Machine Learning
Active, not recruiting NCT04784351 - Prediction of Expected Length of Hospital Stay Using Machine Learning
Completed NCT03203759 - Hospital-Level Care at Home for Acutely Ill Adults N/A
Active, not recruiting NCT03621215 - The Effect of Tart Cherry Juice on Risk of Gout Attacks N/A
Recruiting NCT05658575 - Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare Phase 2/Phase 3
Recruiting NCT03524222 - Home Hospital for Suddenly Ill Adults N/A
Not yet recruiting NCT06273813 - Treatment of Topical Ketorolac Gel in Acute Gouty Flare Phase 1
Completed NCT04531280 - Rural Home Hospital: Proof of Concept N/A
Completed NCT05256303 - Rural Hospital-Level Care at Home for Acutely Ill Adults N/A
Not yet recruiting NCT06207045 - The Effects of Limb Elevation During Gout Flare Episodes N/A
Completed NCT04080570 - Remote Physician Care for Home Hospital Patients N/A